Stryker Corporation (SYK)
NYSEHealth CareMedical DevicesSnapshot 2026-07-08
$326.91-0.86%
Close 2026-07-08 · 1-day change
Reading SYK? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track SYK free→NYSEHealth CareMedical DevicesSnapshot 2026-07-08
Reading SYK? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track SYK free→QuarterlyIQ Insights · SYK
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 25,270.0 | 25,116.0 | 22,595.0 | 20,498.0 | 18,449.0 | 17,108.0 | 14,351.0 | 14,884.0 | 11,325.0 | 11,325.0 | 11,325.0 | 9,946.0 | 8,657.0 | 8,657.0 | 8,657.0 | 8,307.0 | 6,718.2 | 6,718.2 |
| Total Revenues | 25,270.0 | 25,116.0 | 22,595.0 | 20,498.0 | 18,449.0 | 17,108.0 | 14,351.0 | 14,884.0 | 11,325.0 | 11,325.0 | 11,325.0 | 9,946.0 | 8,657.0 | 8,657.0 | 8,657.0 | 8,307.0 | 6,718.2 | 6,718.2 |
| Cost of Revenues | 9,139.0 | 9,051.0 | 8,155.0 | 7,440.0 | 6,871.0 | 6,140.0 | 5,294.0 | 5,188.0 | 3,821.0 | — | — | — | — | — | — | — | — | — |
| Gross Profit | 16,131.0 | 16,065.0 | 14,440.0 | 13,058.0 | 11,578.0 | 10,968.0 | 9,057.0 | 9,696.0 | 7,504.0 | 7,495.0 | 7,495.0 | 6,602.0 | 5,876.0 | 5,876.0 | 5,876.0 | 5,496.0 | 4,586.8 | 4,586.8 |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 8,632.0 | 8,651.0 | 7,685.0 | 7,111.0 | 6,386.0 | 6,427.0 | 5,361.0 | 5,356.0 | 4,137.0 | 4,137.0 | 4,137.0 | 3,610.0 | 3,367.0 | 3,466.0 | 3,466.0 | 3,150.0 | 2,625.1 | 2,625.1 |
| R&D Expenses | 1,631.0 | 1,623.0 | 1,466.0 | 1,388.0 | 1,454.0 | 1,235.0 | 984.0 | 971.0 | 715.0 | 715.0 | 715.0 | 625.0 | 471.0 | 471.0 | 471.0 | 462.0 | 367.8 | 367.8 |
| Operating Income | 4,889.0 | 4,889.0 | 3,689.0 | 3,888.0 | 2,841.0 | 2,584.0 | 2,223.0 | 2,713.0 | 2,175.0 | 2,166.0 | 2,166.0 | 1,861.0 | 1,741.0 | 1,741.0 | 1,741.0 | 1,686.0 | 1,519.0 | 1,519.0 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 47.0 | 47.0 | — | — | — |
| Other Non-Operating Income / Expenses | 230.0 | 232.0 | 212.0 | 148.0 | (158.0) | (303.0) | (269.0) | (151.0) | (254.0) | (245.0) | (245.0) | (126.0) | (36.0) | (36.0) | (36.0) | (22.0) | 61.2 | 61.2 |
| Asset Writedown | 135.0 | 170.0 | 977.0 | 36.0 | 270.0 | 264.0 | 215.0 | — | — | — | — | — | — | — | 76.0 | (76.0) | 76.6 | — |
| EBT, Incl. Unusual Items | 4,600.0 | 4,514.0 | 3,492.0 | 3,673.0 | 2,683.0 | 2,281.0 | 1,954.0 | 2,562.0 | 1,921.0 | 1,921.0 | 1,921.0 | 1,735.0 | 1,705.0 | 1,705.0 | 1,705.0 | 1,686.0 | 1,580.2 | 1,580.2 |
| Income Tax Expense | 1,263.0 | 1,268.0 | 499.0 | 508.0 | 325.0 | 287.0 | 355.0 | 479.0 | 274.0 | 274.0 | 274.0 | 296.0 | 407.0 | 407.0 | 407.0 | 341.0 | 432.4 | 432.4 |
| Net Income | ||||||||||||||||||
| Net Income | 3,337.0 | 3,246.0 | 2,993.0 | 3,165.0 | 2,358.0 | 1,994.0 | 1,599.0 | 2,083.0 | 1,647.0 | 1,647.0 | 1,647.0 | 1,439.0 | 1,298.0 | 1,298.0 | 1,298.0 | 1,345.0 | 1,147.8 | 1,147.8 |
| Per Share | ||||||||||||||||||
| Basic EPS | 8.72 | 8.49 | 7.86 | 8.34 | 6.23 | 5.29 | 4.26 | 5.57 | 4.40 | 4.40 | 4.40 | 3.82 | 3.41 | 3.41 | 3.41 | 3.48 | 2.81 | 2.81 |
| Diluted EPS | 8.63 | 8.40 | 7.76 | 8.25 | 6.17 | 5.21 | 4.20 | 5.48 | 4.35 | 4.35 | 4.35 | 3.78 | 3.39 | 3.39 | 3.39 | 3.45 | 2.78 | 2.78 |
| Revenue per Share | 65.38 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | 3.44 | — | — | — | — | — | — | 0.58 | 0.52 | 0.47 | 1.57 | 1.42 | 0.90 | 0.90 | 0.90 | 0.75 | 0.40 | 0.40 |
| Basic Weighted Avg Shares | 382.9 | 382.2 | 381.0 | 379.6 | 378.2 | 377.0 | 375.5 | 374.0 | 374.1 | 374.1 | 374.1 | 376.6 | 380.6 | 380.6 | 380.6 | 386.5 | 408.1 | — |
| Diluted Weighted Avg Shares | 386.5 | 386.5 | 385.6 | 383.7 | 382.2 | 382.3 | 380.3 | 379.9 | 378.5 | 378.5 | 378.5 | 380.9 | 383.0 | 383.0 | 383.0 | 389.5 | 413.6 | — |
| Payout Ratio | 39.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||||
| EBITDA | — | 6,459.0 | 5,115.0 | 5,229.0 | 4,119.0 | 3,856.0 | 3,299.0 | 3,757.0 | 2,927.0 | 2,918.0 | 2,918.0 | 2,451.0 | — | 2,227.0 | 2,227.0 | 2,167.0 | — | — |
| EBIT | 4,889.0 | 4,889.0 | 3,689.0 | 3,888.0 | 2,841.0 | 2,584.0 | 2,223.0 | 2,713.0 | 2,175.0 | 2,166.0 | 2,166.0 | 1,861.0 | 1,741.0 | 1,741.0 | 1,741.0 | 1,686.0 | 1,519.0 | 1,519.0 |
| Effective Tax Rate | 27.5% | 28.1% | 14.3% | 13.8% | 12.1% | 12.6% | 18.2% | 18.7% | 14.3% | 14.3% | 14.3% | 17.1% | 23.9% | 23.9% | 23.9% | 20.2% | 27.4% | 27.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.